MTMintoo Tergestina

Mintoo Tergestina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mintoo Tergestina has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Maternal Educational and Coaching Intervention to Support Breastfeeding Self-Efficacy in Mothers of Very Preterm Infants: A Non-Randomized Clinical Trial

    by Hima B. John, Ashara T., Mintoo Tergestina, Anil Kuruvilla, Grace Rebekah, Sanjeev M. Padankatti

    This non-randomized clinical trial evaluated whether a maternal educational and coaching intervention improved breastfeeding self-efficacy, performance, maternal anxiety, and duration of exclusive breastfeeding. Mothers of very preterm infants participated in two educational-coaching sessions. Fifty-five mother–infant dyads (28 in the intervention and 27 in the control group) participated in this study that compared usual care with a two-session maternal educational and coaching intervention in addition to usual care. At discharge, the intervention group had higher scores in the Breastfeeding Self Efficacy Scale ( M [ SD ] = 64.6 [5.5] vs. 55.48 [8], p < .01, 95% CI = [−12.9, −5.34]), the Preterm Infant Breastfeeding Behavior Scale ( M [ SD ] = 17.17 [1.82] vs. 13.30 [2.37], p < .01, 95% CI = [−5.03, −2.70]) and lower rating using the General Anxiety Scale ( M [ SD ] = 12.67 [17.13] vs. 40.74 [26], p < .01, 95% CI = [19.4, 33.4]), compared to the control group. Rates of exclusive breastfeeding were higher in the intervention group at 1 week post-discharge (100% vs. 82%, p = .023), at 3 months (96% vs. 48%, p ≤ .01), and at 6 months (89% vs. 37%, p ≤ .01). The intervention was associated with improved maternal breastfeeding self-efficacy and breastfeeding outcomes in preterm infants.

  • Incidence and outcomes of newborn admitted with severe meconium aspiration syndrome over a 17-year period in a tertiary care centre in India

    by Sutharson Ramasamy, Shaik Naseeruddin, Mintoo M. Tergestina, Benjamin Jeyanth Ross, Prasanna Samuel, Manish Kumar, Sridhar Santhanam

    Meconium aspiration syndrome (MAS) is one of the common causes of respiratory distress among newborn. Severe MAS is associated with considerable morbidity and mortality, and there is sparse data on this entity from large studies from low- and middle-income countries. To determine the incidence of meconium aspiration syndrome (MAS) and severe MAS in a large perinatal centre over a 17-year period and to study the clinical course, complications, and outcomes of newborn with severe MAS. This was a retrospective study of babies admitted in the unit between 2006 and 2022. The list of babies with a diagnosis of MAS was extracted from the admission register and cross-checked with the ventilation database and discharge summaries. Relevant maternal, perinatal as well as postnatal courses, investigations, and outcomes were collected from the clinical workstation and the summaries. During the 17-year period, there were 206 377 deliveries in the hospital. There were 1294 babies admitted with MAS; 146 (11.3%) babies satisfied the criteria for severe MAS. With 73 of these newborn being inborn, incidence of severe MAS was 3.5/10 000 (95% CI 2.7–4.3/10 000) live births among inborn babies. High-frequency ventilation was required in 54 newborn (37%). The median duration of ventilation was 4 days (IQR 3–7 days). Sixteen babies had pulmonary air leak (11%) and persistent pulmonary hypertension (PPHN) was present in 63 babies (43%). The median length of hospital stay was 13 days (IQR 9–18). Of the 146 newborn with severe MAS, 118 survived (80.8%). Adverse outcome was associated with presence of PPHN [OR-5.24 (95% CI 1.7–15.9)] and pneumothorax [OR-17.3 (95% CI 3.5–85.2)]. Sixty-nine (53.9%) of the survivors had long-term follow-up. Adverse neurodevelopmental outcomes were present in 7.8% of neonates, which included developmental delay, microcephaly, cerebral palsy, seizure disorder, autistic traits, and hearing loss. A small proportion (11.3%) of babies with MAS had severe MAS. Nearly one-fifth of babies with severe MAS had adverse short-term outcome. The presence of PPHN and air leaks were significantly associated with adverse outcomes.

  • Open Access

    Neonatal compartment syndrome

    by Sirisha Andey, Kiran Sasi, Binu P Thomas, Mintoo Tergestina


  • Severe neonatal autoimmune thrombocytopenia secondary to maternal Evans syndrome

    by Shafini Beryl, Benjamin Jeyanth Ross, Mintoo Tergestina, Manish Kumar

    Evans syndrome is a rare and chronic autoimmune disease seen in both paediatric and adult age groups. We present a case of severe thrombocytopenia in a neonate born to a mother with Evans syndrome who showed no response to intravenous immunoglobulin therapy initially and improved after treatment with methylprednisolone.


  • Foot Length for Gestational Age Assessment and Identification of High-Risk Infants: A Hospital-Based Cross-Sectional Study

    by Mintoo Tergestina, Shanu Chandran, Manish Kumar, Grace Rebekah, Benjamin J Ross

    The knowledge of the gestational age of the newborn is essential for management. In the absence of a dating scan, the postnatal assessment scores have drawbacks of being difficult to learn and administer in the community. The measurement of the foot length is easy, reproducible and offers an objective assessment. The objective of this study was to determine the correlation of postnatal (<48 h) foot length measurement (with calipers) with gestational age as determined by antenatal dating ultrasound, create a predictive model for the same and propose foot length measurement cutoffs for <37 and <34 weeks of gestation. Secondary objectives were to assess the correlation between foot length as measured with calipers and that measured with a ruler and a paper footprint. This was a hospital-based cross-sectional study. Among the 520 babies assessed, the correlation of foot length with gestational age was 0.89. Operational cutoffs for the categories of <37 and <34 weeks at a sensitivity of 95% were <70 and <65 mm, respectively. The Pearson’s correlation between foot length as measured by caliper and ruler was 0.95 and between caliper and paper footprint was 0.87. This study correlating foot length and gestational age has the potential to help neonatal care providers make informed management decisions, particularly in resource-limited settings.


  • Open Access

    Effects of Antenatal Magnesium Sulfate on the Gut Function of Preterm (<32 weeks) Very Low Birth Weight Neonates: Experience from a Tertiary Institute in South India

    by Shanu Chandran, Mintoo Tergestina, Benjamin Ross, Avadhesh Joshi, Grace Rebekah, Manish Kumar

    Antenatal magnesium sulfate (MgSO4) is found to have various adverse effects in newborn, but the effect on preterm gut is still unclear. This study aimed to evaluate the effects of antenatal MgSO4 on preterm gut function by assessing the clinical outcomes and mesenteric blood flow. This was a prospective cohort study on all preterm very low birth weight (VLBW) neonates born at a tertiary care center in South India from November 2016 to August 2017. Neonates with antenatal magnesium (Mg) exposure were compared with those with no exposure for various neonatal outcome variables like time to reach full feeds, feed intolerance, necrotizing enterocolitis (NEC) and other preterm complications, serial serum Mg levels and superior mesenteric artery (SMA) Doppler velocity measurements at two time points (24–48 h and 4–5 days after birth). Out of 84 neonates, 56 neonates were exposed to antenatal Mg with a median cumulative maternal dose of 28 g and the rest 28 neonates had no exposure. The mean time to reach full feeds was the same in both groups (10.5 days). Feed intolerance episodes were similar in the first week of life between the exposed and unexposed groups (48.2% vs. 46.4%; p = 0.88). Univariate analysis revealed no difference between groups concerning rates of NEC (p = 0.17) or mortality (p = 0.39). There was no significant difference in SMA Doppler parameters and hypermagnesemia between the two groups. Our study found no significant impact on postnatal feed tolerance and mesenteric blood flow among preterm VLBW neonates with antenatal MgSO4 exposure.